Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic...

Area of Science:

• Immunology
• Microbiology
• Pharmacology

Background:

• Toll-like receptor 5 (TLR5) signaling is crucial for innate immune responses against bacterial pathogens.
• Flagellin, a TLR5 agonist, has shown promise in enhancing antibacterial defenses.
• Previous studies indicated flagellin combined with amoxicillin (AMX) improves treatment for Streptococcus pneumoniae pneumonia.

Purpose of the Study:

• To investigate the impact of adjunct flagellin therapy on antibiotic dosage and the selection of antibiotic-resistant Streptococcus pneumoniae.
• To evaluate the therapeutic efficacy and resistance selection dynamics of flagellin combined with amoxicillin.

Main Methods:

• Superinfection models using isogenic antibiotic-sensitive and antibiotic-resistant Streptococcus pneumoniae strains.
• Population dynamics analysis to assess bacterial clearance and resistance selection.
• Development of a mathematical model to quantify immune-modulatory effects.

Main Results:

• Adjunct flagellin therapy enabled a 200-fold reduction in amoxicillin dose while maintaining therapeutic effectiveness.
• Flagellin treatment reduced the selection of antibiotic-resistant bacteria compared to amoxicillin monotherapy.
• A mathematical model estimated a 20-fold enhancement in immune-mediated bacterial clearance.

Conclusions:

• Adjunct flagellin therapy offers a strategy to reduce antibiotic dosage and mitigate the development of antibiotic resistance.
• This host-directed approach holds potential for refining treatment regimens against bacterial infections.
• Mathematical modeling provides valuable insights into immune-modulatory factors influencing treatment outcomes.